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ABSTRACT 
 
Yalamanchili, Hima Bindu. Ph.D., Biomedical Sciences, Ph.D. Program, Wright 
State University, 2018. A novel approach for cancer characterization using Latent 
Dirichlet Allocation and Disease-Specific Genomic Analysis 
 
 
              Two challenging problems in the clinical study of cancer are the 
characterization of cancer subtypes and the classification of individual patients 
according to those subtypes. Further, understanding the role of differential gene 
expression in the development of and molecular response to cancer is a complex 
problem that remains challenging, in part due to the sheer number of genes and 
gene products involved. Traditional statistical approaches addressing these 
problems are hindered by within-class heterogeneity and challenges inherent in 
data integration across high-dimensional data. In addition, many current machine 
learning methods do not lend themselves to biological interpretation. We have 
developed a novel Latent Dirichlet Allocation (LDA)-based classification 
approach to classify unknown samples based on similarity of co-expression 
patterns and mitigate these challenges. Integrating this approach with several 
recently-developed feature engineering and visualization methods, including 
Disease Specific Genomic Analysis (DSGA) and topological data analysis (TDA), 
we developed an analysis pipeline that achieves high accuracy compared to 
state-of-the-art approaches. We demonstrate the effectiveness of this pipeline on 
several data sets including RNA-Seq data from Illumina HiSeq 2000 for breast 
v 
 
cancer and lung cancer identification, mRNA expression data from Agilent Hu25k 
microarray for breast cancer subtype identification and copy-number data from 
Affymetrix SNP6.0 for melanoma identification. We also present functional 
analysis to identify relevant genes and the associated pathways that could 
potentially be involved in differentiating different tumor types. 
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I. INTRODUCTION 
 
Cancer is a disease of the genome that arises through genetic 
alterations in cells. Cancer is among the leading causes of death worldwide, with 
approximately 14 million deaths annually (Ferlay, 2013). Recent projections find 
that the most common cancers include breast cancer, lung cancer, colon cancer, 
melanoma of the skin, prostate cancer, pancreatic cancer and leukemia. 
 
Breast cancer is one of the most common fatal cancers among women. 
More specifically, breast cancer constitutes about 22.9% of all cancers in women 
excluding skin cancer. Discovering breast cancer in its early stages and 
delivering appropriate therapy promises to reduce the mortality rate; however, 
breast cancer is becoming increasingly recognized as not just one disease, but a 
group of diseases varied by different molecular subtypes, risk factors, and clinical 
behaviors, that lead to different treatment responses (Ng CK et al., 2012). Thus, 
accurate grouping of breast cancers into clinically relevant subtypes is important 
and can aid in directing patient therapy. There are various factors considered in 
classifying breast cancers including origin, stage, grade, histopathology, and 
receptor status. Cancer originating from the lobules is called lobular carcinoma, 
from the ductal cells is called ductal carcinoma and cancer that spreads from the 
origin into other tissues is called invasive carcinoma. Cancer limited to the tissue 
of origin is termed as non-invasive carcinoma. Depending on the size and spread 
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of the tumor, breast cancer can be further classified into Stages 0, 1, 2, 3 and 4. 
Based on the similarity and amount of differentiation of cancerous tissue 
compared to healthy tissue, classification can be either Grade 1, Grade 2 or 
Grade 3. Histopathology is the direct observation of the cancerous tissue from 
biopsy. 
Another type of classification is based on receptor status. Currently there 
are three main types of receptors observed in breast cancer cells which help in 
deciding the course of treatment: estrogen receptor (ER), progesterone receptor 
(PR) and human epidermal growth factor receptor 2 (HER2/neu). Breast cancer 
cells that have ER, PR or HER2 receptors require corresponding hormones for 
growth and are labelled ER+, PR+ and HER2+ respectively. Blocking of these 
hormones or receptors with drugs can stop the growth of cancer. For example, in 
case of HER2, monoclonal antibodies like trastuzumab are designed to bind to 
the protein and make it unavailable for cancer cells (Romond et al., 2005). 
 
            Based on these receptors, there are at least five distinct molecular breast 
cancer subtypes reported in previous studies (Perou et al., 2000). These include 
basal, HER2, luminal A, luminal B, and normal-like. These subtypes have their 
own genetic signature and may require different treatment regimens (Fasching 
PA et al., 2011, Sotiriou et al., 2003). Luminal A is the most common breast 
cancer subtype, accounting for 40% of breast cancers. These tumors tend to be 
ER+ and/or PR+ and HER2-. Luminal B constitutes about 10% to 20% of breast 
cancers (Perou et al., 2011, Voduc et al., 2010). Like luminal A tumors, most 
luminal B tumors are ER+ and/or PR+, but they are distinguished by either 
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expression of HER2 or high proliferation rates (Cheang, et al., 2009). Luminal A 
and luminal B tumors are associated with more positive short-term prognosis 
because the expression of hormone receptors is predictive of a favorable 
response to hormonal therapy. About 10% to 20% of breast cancers are basal-
like and are referred to as triple negative because they are ER-, PR-, and HER2- 
(Carey et al., 2006, Voduc et al., 2010). Basal-like tumors also express 
myoepithelial markers (CK5, CK14, CK17 and laminin) and overexpress EGFR. 
Women diagnosed with basal-like breast cancer have a poorer short-term 
prognosis than those diagnosed with other breast cancer subtypes because 
there are no targeted therapies for these tumors. About 10% of breast cancers 
produce excessive HER2 (a growth-promoting protein) and do not express 
hormone receptors (ER- and PR-; Perou, 2011). About 5-10% of breast cancers 
are normal-like and lack ER, PR and HER2. Unlike basal, they lack CK5 and 
EGFR and express gene characteristics of adipose tissue. Significance of 
normal-like tumors is undefined, and some studies consider these to be an 
artifact resulting from high percentage of normal cells in tumor specimen (Parker 
et al., 2009, Peddi et al., 2012). The breast cancer taxonomy including the five 
molecular subtypes (luminal A, luminal B, basal-like, HER2 and normal-like) is a 
working model, and that additional molecular subtypes with distinct molecular 
aberrations and clinical behavior will be identified. In fact, recent studies have led 
to the identification of c-myc (Nicolau et al., 2011), Claudin-low (Herschkowitz et 
al., 2007) and molecular apocrine subtypes (Prat et al., 2010), whose clinical and 
biological significance remain to be fully elucidated. Taken together, these 
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observations demonstrate that the final molecular taxonomy of breast cancer is 
likely to be more complex than initially visualized (Perou et al. 2000). A great deal 
of research is being done on breast cancer and its subtypes to identify changes 
in molecular function and develop therapeutic targets. 
Lung cancer is the second most common cancer in both men and 
women (cancer.org). Based on their appearance under a microscope, the two 
main types of lung cancer are non-small cell and small cell lung cancer (SCLC). 
The non-small cell lung cancer (NSCLC) is the prevailing form of lung cancer and 
is responsible for 85% of the total lung cancers in America (American Cancer 
Society, 2016). The most common tumors in this category are adenocarcinoma 
(about 40%), lung cancer in nonsmokers, and squamous cell carcinoma (about 
25-30%), which is a lung cancer that is positively correlated with tobacco 
smoking (Anagnostou, et al., 2012). Whereas adenocarcinoma is formed in 
glands that secrete mucus or fluids in different parts of the body, squamous cell 
occurs in the bronchi within the central region of the chest. The remaining 15% of 
lung cancers are SCLC. In the body, this type of cancer spreads relatively 
quickly, exhibiting a higher growth rate and shorter multiplying time. 
Chemotherapy is a more effective treatment for SCLC. Diagnosis is a critical 
challenge in treating lung cancer. Two-thirds of lung cancer patients are 
diagnosed at late, metastatic stages (2% survival rate) whereas 49% of patients 
diagnosed early will likely survive longer (Leidinger et al., 2010). Current 
prognosis for lung cancer patients is poor (<=15%) creating a need for new and 
improved therapeutic strategies (Brambilla et al., 2009). 
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Skin cancer is the most common of all cancers in the United States. 
There are 5.4 million new cases of skin cancer in the U.S. every year (Rogers et 
al., 2015). Melanoma and nonmelanoma are the two forms of skin cancer. 
Melanoma arises from the malignant transformation of epidermal melanocytes, 
pigment-synthesizing cells of the skin. Although melanoma is the rarest form of 
skin cancer (2% of skin cancer), it accounts for the majority (75%) of skin cancer 
related deaths. Melanocytes can give rise to either benign (i.e., nevi) or 
malignant (i.e., melanoma) growths. In most of the cases, dermatopathologists 
can accurately distinguish a nevus from melanoma. However, certain ambiguous 
histopathological features overlap between nevi and melanoma leading to 
diagnostic difficulty. Such uncertainty and ambiguity in melanoma diagnosis often 
leads to misdiagnosis, increased medical costs, unnecessary stress, and 
negligence of the disease (Corona et al., 1996, Lodha et al., 2008). Some of the 
approaches for evaluating melanocytic tumors include Hematoxylin and Eosin 
(H&E) staining, immunohistochemical staining, and fluorescent in situ 
hybridization (FISH) assays (Dorvault et al., 2001, Wang, L et al., 2013). Based 
on the 5-year survival rate of melanoma, early diagnosis is the most effective 
way for long-term survival of melanoma patients. 
 
Accurate cancer diagnosis and classification of tumors types is crucial 
for the successful application of specific therapies. Conventional classification 
techniques primarily based on morphological and clinical characteristics of the 
tumor have been reported to have limitations (Azuaje, 2000). Tumors with similar 
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histopathological appearance can be molecularly heterogeneous, differently 
responsive to therapy, and thus may require different clinical courses (Azuaje, 
2000). To gain better insight into this issue, cancer detection based on genomic 
data has been widely explored (Meyerson et al., 2010). 
 
Recent studies demonstrated that DNA microarrays could provide useful 
information for cancer classification at the gene expression level, due to their 
ability to measure the abundance of messenger ribonucleic acid (mRNA) 
transcripts for thousands of genes simultaneously. For example, Alizadeh et al; 
(2000) identified two previously unknown groups of large B-cell lymphoma 
(DLBCL) using gene expression profiling. Bittner et al; (2000) were able to 
identify previously unrecognized subtypes of cutaneous melanoma by gene 
expression studies of 31 melanoma biopsies. One study by Sorlie et al; (2001) 
found gene expression profiles that could be used as prognostic markers for 
overall and relapse-free survival in breast cancer tissue. Ramaswamy et al; 
(2003) found 128 genes differentially expressed between primary and metastatic 
adenocarcinomas. Roepman et al; (2005) built a gene predictor that could detect 
local lymph node metastases in primary head and neck squamous cell 
carcinomas. Application of microarrays in these studies helped create a better 
understanding of the biology, diagnosis and treatment of cancer. 
 
While microarrays are widely used and have shown great promise over the 
years, they do have certain limitations: 1) Microarray design requires a priori 
knowledge of the genome or genomic features. This restriction affects array 
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effectiveness in cases of incomplete or outdated genome annotations. 2) Cross-
hybridization can happen between similar sequences. 3) The variety of available 
microarray formats, preparative methodologies and analytical approaches may 
limit the reproducibility of microarray data between studies. 4) Another obstacle is 
the high signal to noise ratios: That is, because of saturation in fluorescence, it is 
difficult to differentiate between two very highly expressed transcripts, even with 
a significant difference between the two. Also, it’s easy for the expression of low-
abundance transcripts to get lost in the noise inherent to microarrays. Other 
limiting factors are normalization, interpretation, and the cost. Microarray 
experiments must be normalized to account for the noise difference. However, 
there is no general agreement on how normalization should be done, and 
normalization procedures tend to be different from experiment to experiment 
(Draghici, 2001). Another limitation is the overall cost of the experiment. Many 
experiments require several arrays with different samples that could potentially 
increase the cost of the experiment. 
 
The great depth of sequencing offered by Next-generation sequencing 
(NGS) made them available to various applications for which DNA microarrays 
had been used, while overcoming many problems associated with the latter. The 
term ‘Next-generation sequencing’ applies to several commercially available 
platforms. The most commonly used NGS platforms are 454 pyrosequencing 
(Roche/454 Life Sciences), ion semiconductor (Ion Torrent sequencing), 
sequencing by synthesis (Illumina sequencing), sequencing by ligation (SOLiD 
sequencing) and nanopore sequencing. NGS-based approaches offer 
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advantages compared to microarrays: 1) Knowledge of genome annotation is 
helpful, but not required. It can identify previously uncharacterized mRNA 
isoforms and new classes of non-coding RNAs, as opposed to microarrays, 
which provide relative quantitation only for probe sequences specifically included 
on the chip being used. 2) Genetic material is directly sequenced removing 
cross-hybridization issues from the analysis. 3) Because all next-generation 
platforms have the same data output (a record of sequences), it is hoped that the 
reproducibility of experiments will be much improved over a variety of microarray 
platforms. 4) Quantification of signal from sequence-based approaches is based 
on counting sequence tags rather than relative measures between samples, thus 
eliminating the high signal to noise ratio. On the other hand, some limitations of 
NGS technologies are producing short read-lengths that tend to complicate 
interpretation of results in some instances and the need for extensive analytic 
capability. 
 
Analysis of high-throughput gene expression data is a challenging task, 
often complicated by small sample size (typically in the tens) and large number of 
gene expression values (high dimensionality, typically in the tens of thousands). 
With such a huge dimensionality space, classical statistical or computational 
methods are likely to over-fit the data. Selection of relevant genes involved in 
different types of cancer (feature selection) is also a challenge. Several machine 
learning methods have been applied to this problem because of their ability to 
model non-linear relationships and construct interpretable models. 
Machine Learning 
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Machine Learning is a field of artificial intelligence that uses algorithms to 
find patterns in data and make predictions about future events. In machine 
learning, observations are generally referred to as instances and the variables 
are called features or attributes. Observations, then, are thought of as data points 
in a d-dimensional space, where d is the number of features measured 
(dimensionality). In practice, machine learning algorithms are employed in two 
phases: the training phase during which the algorithm model’s data properties 
associated with each class; and the testing phase, during which the algorithm 
uses the trained model to predict the class of new data. There are two main 
types of machine learning methods: supervised learning and unsupervised 
learning. In supervised learning, a labeled set of training data (i.e., target labels) 
is used to map the input data to the output. In contrast to supervised learning, 
target labels are not present in unsupervised learning and the algorithm tries to 
find similarity among groups/clusters within the data. Another type of machine 
learning method is semi-supervised learning, which combines both labeled and 
unlabeled data to construct an accurate learning model. Usually, this type of 
learning is used when there is more unlabeled data than labeled. Depending on 
the classification task and the data available, the algorithm required can be a 
supervised, unsupervised or semi-supervised model. Some of the most 
commonly used algorithms that will be applied in this project are discussed here: 
 
Unsupervised learning 
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The k-means algorithm, where k is the number of clusters 
(MacQueen,1967), is one of the simplest unsupervised learning algorithms. It 
begins by creating k centroids, and iterates between an assign step, where each 
sample is assigned to its closest centroid and an update step, where each 
centroid is updated based on the mean of all samples assigned to the cluster. 
This iteration continues until some stop criterion is met. 
Hierarchical clustering is based on distance connectivity. It can be either 
agglomerative, which considers each sample as a separate cluster and then 
merges the clusters; or divisive, which starts by considering all samples as single 
clusters and then divides the cluster into sub-clusters, and so on (Rokach Lior, 
2005). The distance between clusters is based on the distance between 
individual samples. In ‘single linkage’, the distance between two clusters is the 
minimum distance between any sample in the first cluster and any other sample 
in the second cluster. In ‘complete linkage’, the distance between two clusters is 
the maximum distance and in ‘average linkage’, it is the average distance 
between the samples. The arrangement of the clusters produced by hierarchical 
clustering can be illustrated with a dendrogram, which is a useful approach to 
illustrate the results. 
 
Supervised learning 
 
K-nearest neighbor (k-NN) classification is one of the simplest machine 
learning methods. It takes the most frequent class as measured by the weighted 
Euclidean distance (or some other distance measure) among the k-closest 
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training examples in the feature space. Drawbacks of this model include slow 
classification times, high memory usage, and a propensity for overfitting the 
training data. In some cases, these can be mitigated by using dimensionality 
reduction algorithms. There have been concerns regarding the use of k-nearest 
neighbor with cancer data sets, especially when the class distribution is skewed. 
That is, this technique tends to assign the new sample, a more frequent class 
because they are common among the k nearest neighbors due to their large 
number. However, recent considerations have shown that one way to overcome 
this problem is to weight the classification, considering the distance from the test 
point to each of its k nearest neighbors. 
 
Support Vector machines (Vapnik, 1995) work by classifying instances 
based on a linear function of the features. The goal of a support vector machine 
is to search for a hyperplane that maximizes the margin between two classes, 
where margin is defined as the distance between selected (boundary) data points 
of the different classes ("support vectors"). If the data is not linearly-separable, 
the support vector machine may employ a kernel to map the data to a higher 
dimensionality space in which the classes can then be separated by some 
hyperplane. The three most popular kernel methods are: linear, polynomial, and 
radial basis functions. 
 
Naive Bayes (NB) Naive Bayes (Hill, 1965; Langley et al., 1992) is a 
probabilistic classifier based on bayes theorem. Naive bayes estimates the 
probability of an instance belonging to a class given the class probability, which 
is the probability of class in a dataset and conditional probability, which is the 
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probability of the feature value. It assumes conditional independence among all 
variables given the class label. A growing trend is noted the last decade in the 
use of supervised learning techniques, namely SVMs and NB towards cancer 
prediction and prognosis (Akay 2009, Chuang et al., 2011, Eshlaghy et al., 
2013). 
Decision trees use a tree-like branching approach to classify instances 
(Quinlan, 1986). Each node in the tree represents a test of some attribute of the 
instance, and each branch from that node represents the possible value for that 
attribute. The path from the root node, moving down tree branch to the leaf 
represents classification rules to classify an instance. An advantage of the 
decision tree is that it is very simple to understand and interpret. Several reports 
have successfully used decisions trees for gene identification and classification 
within cancer datasets (Chen et al., 2014, Elouedi et al., 2014) 
 
Disease-Specific Genomic Analysis (DSGA) is a specialized case of 
clustering and class prediction. DSGA can be used in microarrays, DNA, RNA, 
and any other high-dimensional genomic or proteomic data and in some 
experiments, has outperformed standard clustering methods (Nicolau et al., 
2007). DSGA first models the normal gene expression data and subsequently 
extracts the disease-specific component as a deviation from normal (Nicolau et 
al., 2007). That is, normal gene expression data is modelled by dimensionality 
reduction using an approach like principal component analysis. Next, each 
cancer gene expression profile is fit to this normal model and the residual is 
defined as the disease-specific component (Figure 1). 
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Figure 1 Representation of DSGA 
The figure illustrates the decomposition of tumor data vector into the normal and 
disease components. Copyright acknowledgement to “Monica Nicolau et al. 
Disease-specific genomic analysis: identifying the signature of pathologic biology 
Bioinformatics (2007) 23 (8): 957–965 
 
Text Mining 
 
Another important application of machine learning that has received 
considerable attention is related to World Wide Web and document retrieval. For 
example, when we search on the World Wide Web using a search engine, it is 
just looking for words in common: if there is one document about hormonal 
regulation and ovarian cancer, and another document about differential gene 
expression in breast cancer, they may not appear to have words in common, but 
it is important to identify that there are commonalities in those documents: they 
are about cancer and gene regulation. Text mining techniques are designed to 
reveal such concepts/relationships in textual data that are not visible to the naked 
eye. We used this advantage of being able to identify the relationships that aren’t 
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evident and apply the same power to infer relationships that can help differentiate 
between cancerous and healthy tissues based on topics identification. 
 
Topic modeling is a machine learning approach most commonly employed 
in text mining to reveal the underlying thematic structure of documents (Blei, 
2002). In topic modeling, a document is described as a mixture of topics, each 
with a specific probability distribution over the set of available words. Topic 
modeling has shown promise in the fields of text mining and image retrieval, 
where it has been successfully implemented to extract information from high-
dimensionality data (Andrzejewski, 2006; Song, 2013). Given the successful 
implementation of topic models in discovering the useful structure of the 
documents, topic modeling was also used to analyze data other than document 
collections (Chen et al. 2012, Rogers, 2005, Zhao et al. 2014). Its wide 
application can be attributed to its interpretability and effectiveness in handling 
large datasets. Latent Dirichlet Allocation (LDA) is one of the most popular topic 
modeling approaches in text mining among others like Latent Semantic Indexing 
(LSI) and Probabilistic Latent Semantic Analysis (PLSA) (Deerwester, 1990; 
Hofmann, 2001). 
 
Latent Dirichlet Allocation (LDA) is probably the earliest and most widely-
used unsupervised topic model. LDA is a probabilistic model that transforms a 
collection of discrete data into a set of latent (hidden) relations in the form of 
topics (Blei et al, 2003). Because of its strength for finding underlying relations, 
LDA has been broadly applied in various domains like web-spam filtering, 
analyzing trends in science publications, and exploring blog conversations. 
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In case of text documents, LDA automatically discovers the underlying 
topics those documents contain. The input of LDA is typically a simplified “bag-of-
words” representation of a corpus. In this representation, a corpus is reduced to 
a multiset of words, maintaining word counts, but disregarding context, order, 
and structural features. The algorithm does not know what a word really means, 
but it does discover related words due to co-occurrence. The algorithm can be 
represented as a graphical model as described in Blei et al. (2003) shown in 
Figure 2. 
 
In the given model, rectangles termed as plates represent replicates, 
circles represent nodes/variables, and arrow direction shows dependency of the  
 
 
 
            
 
 
 
 
 
 
Figure 2 Graphical representation of LDA 
The boxes are “plates” representing replicates. The outer plate represents 
documents, while the inner plate represents the repeated choice of topics and 
words within a document. Adapted from Blei et al. 2003, Journal of Machine 
Learning Research 993-1022 
 
variables. A corpus is defined as a collection of M documents, each with a 
sequence of words W. The inner plate represents Z topics and N words within a 
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document. α and β are hyperparameters for the Dirichlet distribution, used for 
generating a topic-distribution to draw a topic Z, and a word-distribution to draw a 
word W respectively. The model runs through several iterations of assigning 
words to topics to improve the model. The resulting output is a word-topic 
distribution, a list of probabilities of words in a topic, and a topic-document 
distribution, a list of proportions of documents in a topic where it is assumed that 
a document consists of one or more topics. Each document is a mixture of topics 
summing up to 1. 
 
The output of LDA reflects its ability to cluster the documents with similar 
topic-document probability. Nonetheless, LDA is not only a clustering algorithm 
but can also interpret the results based on word-topic probability distribution. It 
allows data to come from mixture of topics instead of one topic which is critical 
for various biological applications. An advantage of LDA is that it can be adapted 
to other analysis keeping the analogy between document, topic and word. For 
example, much like the words in a document are driven by what that document is 
about, we can imagine a document as a collection of topics and the select words 
from those topics to fit into the document. Similarly, a snapshot of gene 
expression of an individual is driven by biological processes that are topic-like, 
and that the mRNAs that are expressed in a given cell or tissue at a specific time 
are a stochastic result of the combination of biological states and processes 
active in that cell or tissue. That is, topics can be synonymous to processes and 
words are synonymous to transcripts. 
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Topological Data Analysis (TDA) 
 
Another approach to unsupervised learning is lower-dimensionality 
embedding and visualization, and one example to this is Topological Data 
Analysis (others are t-SNE, isomap, etc.) with regards to data analysis of high 
dimensional data. Although there exist various machine learning methods that 
aim to uncover the geometric structure of data including clustering, manifold 
learning and nonlinear dimensionality reduction, most of them produce 
unstructured scatterplots and distinct, unrelated groups. These methodologies 
involve transforming original data in a way that loses some potentially valuable 
information and sometimes obscure geometric features, which topological 
methods capture. For instance, dimensionality reduction algorithms such as 
principal component analysis (PCA) and multidimensional scaling (MDS) 
transform the original data, wherein data points well apart in original dimensions 
overlap in reduced dimensions eventually. 
 
Topological Data Analysis (TDA) on the other hand leaves data in its 
original, high-dimensional space and can find interesting patterns/clusters in 
data, and the feature of clusters will be carried out even after running the 
algorithm. TDA uses ideas from algebraic topology and aims to uncover relevant, 
qualitative and quantitative topological structures underlying complex and 
possibly high dimensional data (Carlsson, 2009). The basic motivation behind 
TDA is that data has shape and shape has meaning that might help us discover 
relationships and patterns in data. The two most popular approaches in TDA are 
the Mapper algorithm (Singh et al., 2007) and persistent homology (Edelsbrunner 
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et al., 2002). The Mapper algorithm is visualization method that preserves 
topological structure to be interpreted by human or machine, whereas persistent 
homology provides a framework and efficient algorithms to encode the evolution 
of the topology of shape from small to large scale. 
 
TDA has gained tremendous popularity recently due to its generality that 
can be applied to any type of data (Nicolau et al., 2011, Severksky et al., 2015). 
However, the output from TDA may still needs to be interpreted for better 
understanding. As a result, the combination of TDA and machine learning can be 
much more powerful and TDA makes machine learning methods much more 
effective. 
 
Evaluation Metrics 
 
In comparing machine learning models, prediction accuracy (Equation 4) 
is not always the most relevant measure of performance. For example, an 
algorithm designed to predict whether a patient has leukemia can achieve a high 
overall accuracy simply by always predicting "no". Several metrics have been put 
forward in the machine learning community to measure overall model 
performance, considering both false negatives and false positives. A few of the 
most common metrics are sensitivity (Equation 2), specificity (Equation 3), and 
the receiver operator characteristic (ROC) curve. The area under the ROC curve 
(AUC) is a good indicator of overall performance and balance. 
 
A confusion matrix (Figure 3), is a good visualization of the performance 
of a supervised algorithm. A confusion matrix of size c × c (c = the number of 
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classes) represents the rows with actual class and the columns with the 
classifiers predicted class. Several of the metrics mentioned above are 
calculated from the confusion matrix values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Confusion Matrix 
True positive (TP) is the number of positives correctly identified, true negative 
(TN) is the number of negatives correctly identified, false positive (FP) is the 
number of negatives incorrectly identified as positive, and false negative (FN) is 
the number of positives incorrectly identified as negatives. 
 
 
Precision = T P/T P + F P (1) 
Sensitivity (Recall) = T P/T P + F N (2) 
Specificity = T N/T N + F (3) 
Accuracy = TP+TN/TP+FP+FN+TN (4) 
F-measure = 2(precision)(recall)/precision + recall (5) 
 
T P R = T P/T P + F N                                              (6) 
F P R = F P/T N + F P                                              (7) 
 
The Receiver operating characteristic (ROC) curve plots the tradeoffs 
between true positive rate (TPR) (sensitivity/ recall) (Equation 6) and false 
positive rate (FPR) (1-specificity) (Equation 7). The best performance is noted by 
a curve with a small false positive rate and a large true positive rate. A 
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quantitative measure of area under the receiver operating characteristic is called 
AUC. The higher the AUC, the better the classifier performance. 
Calculation of performance on the same data used to train a machine 
learning model can result in a positively biased estimator of true performance. To 
determine whether a trained model will generalize well to new data, it is 
necessary to evaluate the model on data not used during training. Among the 
most commonly-used methods for evaluating the performance of a classifier are: 
holdout, random sampling, cross-validation, and bootstrap. In the holdout 
method, the data samples are split into two disjoint sets, namely the training and 
the test sets. One of the problems associated with the hold-out method is that 
splitting reduces the amount of data available for training. This can be mostly 
eliminated by using random sampling, in which the holdout method is repeated 
several times and chooses different subsets of training and testing instances 
randomly. The performance metric is then averaged. Another potential problem 
of the holdout method is that the performance metric (such as accuracy) can vary 
depending on the distribution of the instances in the training and test sets. Cross-
validation is the process of splitting the dataset into k-equal subsets, where k−1 
subsets are used for training while the remaining subset is used for testing. This 
is repeated k times so that each sample is used the same number of times for 
training and only once for testing. Accuracy is then computed as the average 
accuracies across all cycles. Bootstrap approach works by sampling with 
replacement from the original data. Some samples will be picked more than one 
time and the samples that are never picked are used for testing. 
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II. LITERATURE REVIEW 
 
 
Machine learning in cancer 
 
Many machine learning techniques have been proposed for molecular 
classification of cancer and shown to have statistical and clinical relevance: Self-
organizing maps were used to analyze acute Leukemia (Golub et al., 1999), 
supervised learning approach for predicting outcome in Lymphoma (Shipp et al., 
2001), Brain cancer (Pomeroy et al., 2002), hierarchical clustering for 
identification of distinct adenocarcinoma subclasses (Bhattacharjee et al., 2001) 
and to analyze colon cancer (Alon et al., 1999), a support vector machine was 
applied to classification of multiple primary tumors (Ramaswamy et al., 2001), 
breast cancer (Veer et al., 2002), prostate cancer (Singh et al., 2002), and lung 
cancer (Wang et al., 2014). Recently, Sharma et al; (2012) proposed a gene 
selection algorithm by using Bayes classification approach. It begins with an 
empty feature subset and keeps adding features that provides the maximum 
information to the current subset. This process continues until no feature can add 
information to the current subset. The proposed algorithm is carried out on 
several publicly available microarray datasets including lung cancer and breast 
cancer data and obtained an average accuracy of 96.3%. 
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Machine learning techniques have been increasingly applied to different 
classification and clustering problems, not only for disease identification, but also 
for survival analysis (Zupan et al., 2000), imaging studies (Lu et al., 2015) and 
identification of cancer subtypes. Delen et al; (2005) used artificial neural 
networks, decision trees and logistic regression to develop prediction models for 
breast cancer survival by analyzing a large dataset, the SEER cancer incidence 
database. Computational models such as convolutional neural networks (Ciompi, 
2015), regression trees (Lu, 2015), and support vector machines (Demir, 2015) 
have demonstrated promising diagnostic performance in the analysis of lung 
nodules on CT. However, many automated detection algorithms are insufficient 
for achieving high-specificity beyond the order of 73.91% – 87.87% (Demir, 2015, 
Orozco, 2015). 
 
Breast cancer 
 
Hierarchical clustering of differentially expressed intrinsic genes between 
individual patients first led to the identification of a novel molecular classification 
of breast cancer (Perou et al, 2000). Subsequent studies revealed that similar 
molecular subtypes of breast cancer could be identified in multiple cohorts of 
breast cancer patients and different molecular subtypes were shown to have 
distinct clinical outcomes. For example, Parker et al. (2009) has identified a 50-
gene classifier that has significant prognostic and predictive values on breast 
tumors. Recursive feature addition (RFA), which combines supervised learning 
and similarity measures, was used to select relevant genes to specify the cancer 
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subtypes (Liu, 2009). Reliable identification of significant genes and cancer 
classification based on subtypes have both proven challenging (Negrini, 2010). 
However, because of the lack of stringent standardization of the methodology 
and breast cancer intrinsic subtype definition, different gene signatures 
developed by different studies classify a sample in different categories (Mackay, 
2011). 
 
Rejani et al. (2009) proposed an algorithm for early detection of tumor 
based on mammograms using support vector machines. For each tumor region 
extract, morphological features were extracted to categorize the breast tumor 
and SVM was used for classification. Zhang et al. (2007) proposed a method for 
improving the performance of SVM classifier in breast cancer diagnosis. The 
method is to enlarge margin around separating hyperplane by modifying the 
kernel functions resulting in a remarkable improvement of error and 
computational cost. Recently, Senturk et al. (2014) analyzed the performance of 
seven classification models such as Discriminant Analysis, Artificial Neural 
Networks, Decision Trees, Logistic Regression, Support Vector Machines, Naïve 
Bayes and K-nearest neighbor for the early diagnosis of breast cancer through 
RapidMiner tool and showed that Support vector machine outperforms other 
algorithms with a classification accuracy of 96%. 
Melanoma 
 
With the implementation of clinical algorithms such as the ABCD rule 
(Stolz et al., 1994) and the 7-point checklist (Argenziano et al., 1998), diagnosis 
accuracy for melanoma has improved compared to the naked eye examination. 
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However, these diagnoses are subjective and complex, hence, the accuracy 
relies heavily on the experience of dermatologists, which varies widely (75%- 
85%; Argenziano et al., 2003). In the last few years, a large amount of computer-
aided approaches has been developed for melanoma diagnosis to reduce this 
diagnosis sensitivity. For example, a melanoma recognition system by Ganster et 
al; (2001) was developed using k-NN classification based on image processing. 
A significant amount of work on distinguishing melanoma from nevi has focused 
on machine learning from observation of suspicious moles on the skin (Burroni et 
al., 2004, Tenenhaus et al., 2010). More recently, Tenenhaus et al; (2010) used 
a Kernel Logistic PLS classifier and reported a performance like dermatologists, 
with a sensitivity of 95% and a specificity of 60%. Shrestha et al; (2010) claimed 
accuracy over 95%. Much less work has been done on classifying melanoma 
from nevi based on genetic data. This may be due to the difficulty of diagnosis or 
the number of measurements/features involved. 
Topic modeling applications in bioinformatics 
 
Since the emergence of topic modeling for analyzing large scale text 
corpora, researchers have successfully implemented this approach in biomedical 
text mining (Wang et al. 2009; Bisgin et al. 2011). A survival-LDA (surLDA) was 
applied to patient-related texts to categorize ovarian cancer. Here, each patient is 
considered as a ‘document’, and text from clinical information and treatment 
protocols are represented as ‘words’. On the other hand, there have been efforts 
to use topic modeling techniques in the field of bioinformatics to perform 
unsupervised analysis and obtain insights into high-dimensional omics data. 
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Rogers et al; (2005) and Masada et al; (2009) utilized latent process 
decomposition (LPD) for discovery of clusters across samples and genes. Chen 
et al; (2010) analyzed composition of DNA sequences using LDA. First, DNA 
sequences were represented by N-mer frequencies and later, DNA sequences 
were considered as documents and N-mers as words. A similar effort by Rosa et 
al. (2015) considered genomic sequences as documents, small fragments of a 
DNA string of size k as words, and the topics discovered by LDA are assigned 
taxonomic labels. Pan et al. (2010) proposed a hierarchical latent Dirichlet 
allocation-random forest (LDA-RF) model to predict human protein–protein 
interactions using protein sequence data. First LDA was used to project features 
into topic space, then the probability of interaction of two proteins was predicted 
by a random forest model based on the topic space. 
 
Topic modeling was also applied to image classification. Coelho et al., 
(2010) utilized LDA to identify subcellular localization patterns in fluorescent 
images. Here, an image is represented by a mixture of patterns (topics) and the 
key points as words. To improve the classification accuracy of differentiating 
normal subjects from patients with schizophrenia, Castellani et al; (2010) used 
PLSA and extracted a generative score from the learned model, which was used 
as input in SVM for the classification. Here, each image from magnetic 
resonance imaging (MRI) was a document, the shape of images to be visual 
words, and the geometric patterns of the brain surface were visual topics. More 
recently in the field of bioinformatics, topic modeling has been used for feature 
extraction and clustering from gene expression data (Zhao et al, 2014). While 
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these initial results are promising in clustering, there are many domains where 
application of LDA as a classification approach is unexplored. 
 
Topological data analysis applications  
 
           TDA has been effective in elucidating patterns in high-dimensionality 
data in a variety of different fields ranging from shape classification (Chazal et al., 
2017), clustering and histology images for breast cancer analysis (Singh et al., 
2014). Lum et al., (2012) successfully analyzed three data sets using TDA in 
three very different industries, genetics, political science, and sport performance. 
Topological applications on imaging data have focused mainly on multivariate 
random samples, typically from positron emission tomography (PET) and 
magnetic resonance imaging (MRI) studies (Gamble and Heo, 2010; Lee et al., 
2011; Chung et al., 2015). A popular approach is to model the data as a graph 
based on sites on the brain and join two sites when the distance between them 
exceeds a certain threshold. This approach has also been applied to EEG 
functional networks in a mouse model of depression (Khalid et al., 2014). A 
previously unrecognized subtype of breast cancer was detected in (Monica 
Nicolau, 2011) by topology-based data analysis using microarray data. In their 
paper, the authors introduced a new technique called Progression Analysis of 
Disease (PAD). PAD is a twostep process implemented first by using Disease-
Specific Genomic Analysis (DSGA) followed by using Mapper. The method first 
identifies robust aspects of cluster analysis, then goes deeper to find a multitude 
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of biologically meaningful shape characteristics in the data. They identified a 
unique subgroup of Estrogen Receptor-positive (ER (+)) breast cancers that 
express high levels of c-MYB and low levels of innate inflammatory genes. These 
patients exhibit 100% survival and no metastasis. The group has a clear and 
distinct, statistically significant molecular signature, that highlights coherent 
biology but is invisible to cluster methods and does not fit into the accepted 
classification of Luminal A/B, Normal-like subtypes of ER (+) breast cancers. 
 
HYPOTHESIS 
 
Some of the limitations for machine learning applications in cancer 
biology include choosing the right technique, given the high dimensionality, poor 
gene interpretation and varying class prediction. Most researchers limit their use 
to exploratory data techniques such as PCA or linear regression that are often 
uninterpretable. On the other hand, techniques such as decision trees, 
convolutional neural nets, text mining and ensemble methods are generally 
avoided due to unfamiliarity with using and interpreting techniques, fear of 
misuse and lack of user-friendly implementations.  
Here, we have developed a novel Latent Dirichlet Allocation (LDA)-based 
classification approach to mitigate some of the above challenges and 
subsequently aids in classification of tumor types and gene interpretation. There 
is sufficient analogy between biological process model and textual topic model, 
that LDA will effectively be able to identify processes that we can use to 
differentiate cancer tissue from healthy tissue. Further, LDA topic-word 
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distribution favors gene annotation, thus providing biological interpretation that 
could otherwise be a limitation for majority of the algorithms. Integrating this 
approach with several recently-developed feature engineering and visualization 
methods, including Disease Specific Genomic Analysis (DSGA) and topological 
data analysis (TDA), we developed a novel analysis pipeline. DSGA 
transformation brings out unique biology, allows for wide variability of normal, 
and emphasizes the degree of deviation from healthy tissue (Nicolau et al., 
2007). Since the aim of this project is not only to build efficient classification tools 
but also to bring new insights into biology and medicine, a combination of LDA 
and DSGA is well suited for this type of analysis. 
I therefore hypothesized that, LDA in association with DSGA and 
TDA will effectively classify different cancer types, which in turn achieves 
high accuracy compared to state-of-the-art approaches and allows 
functional analysis to identify relevant genes and the associated pathways 
that could potentially be involved in differentiating different tumor types. 
 
    Based on these strategies, we developed an effective pipeline for 
characterization of different cancer types which include data decomposition using 
DSGA followed by topological data analysis for visualization and finally, class 
prediction using LDA topological data analysis. To demonstrate the effectiveness 
of this approach, I developed the following 3 specific aims. 
 
1. Assess the effectiveness of Latent Dirichlet Allocation (LDA) in classifying 
tumor samples and healthy tissue samples using lung cancer and breast 
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cancer gene expression data and identify known relevant 
features/biological pathways. 
 
 
2. Determine the effectiveness of LDA in classifying different subtypes of 
breast cancer and to identify the genes associated with specific subtypes. 
 
 
3. Assess the effectiveness of LDA in classifying skin cutaneous melanoma 
from benign nevi using copy number data to identify known melanoma 
related genes. 
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III. MATERIALS AND METHODS 
 
Data Collection and Preprocessing 
We obtained the mRNA-Seq data of 229 breast invasive carcinoma samples and 
98 lung squamous cell carcinoma samples from The Cancer Genome Atlas 
(TCGA) data portal (https://portal.gdc.cancer.gov/). We artificially balanced the 
data using only the tumor samples with matched normal samples. Out of 229 
breast cancer samples, 117 represent primary solid tumor and 112 represent 
solid normal tissue. Of the 98 lung cancer samples, half of the data (49) 
represent primary solid tumor and the other half (49) represent solid tissue 
normal. Both datasets have 60483 variables with an abundance of zero values – 
roughly 45% of all values are zero. Genes that have zero expression value in 
more than 10% of samples were removed. This stringent threshold was used to 
prevent any bias (multiple bins having genes with exclusively zero expression 
value) that might arise in the preprocessing step. After filtering, a total of 23424 
genes remained in the breast cancer data and 23996 genes remained in the lung 
cancer data. 
Breast cancer datasets were downloaded from the Nederlands Kanker Instituut 
(NKI) data consisting of 295 tumors and the Breast Cancer Normal (BCN) data 
consisting of 150 normal breast tissue samples. Missing data were imputed using 
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a knn algorithm with k = 10. Data were also transformed from the original log10 
values to log2. Data were then collapsed (mean) by UniGene to the mean. The 
resulting data set consisted of 18,970 UniGene clusters. Copy number data of 63 
skin cancer samples (42 melanoma and 21 benign nevi) were collected. This 
data is from an archive of FFPE skin biopsies collected at a national 
dermatopathology laboratory (Dermatopathology Laboratory of Central States, 
DLCS, Dayton, OH) and processed in the Center for Genomics Research (CGR), 
Department of Biochemistry and Molecular Biology at Wright State University. 
The Copy Number Inference Pipeline in GenePattern from Broad Institute was 
used to convert Affymetrix SNP6 CEL files to generate segmented copy number 
calls for each sample. Segmentation of neighboring CNVs into CN-gain 
segments and CN-loss segments was performed based on the copy number 
values using circular binary segmentation (CBS) with the default parameters in 
DNACopy using scripts written in the R programming language. 
Ranking and Corpus generation 
 
One of the challenges in using LDA for genetic studies is the nature of the 
data. The input of topic modeling is typically a simplified bag-of-words 
representation of a corpus. However, gene expression data is numerical in 
nature, and thus needs to be transformed into text to provide appropriate input 
for the LDA algorithm. The most commonly used transformation method is 
scaling the gene expression matrix and interpreting the discrete values as 
gene/word occurrences. The higher the expression value, the higher the 
frequency of the gene in the bag-of-words (Bicego et al, 2010; Pratanwanich, 
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2014). One limitation to using this approach is that genes that have zero 
expression value will not be present in the training corpus. Consequently, this 
transformation approach is suitable for clustering and feature reduction, but not 
for classification because the test data might have genes that are unseen by the 
trained model. 
 
Rogers et al (2005) used Latent Process Decomposition (LPD), a derivative 
of LDA, to capture the continuous nature of gene expression data. No significant 
difference in terms of accuracy has been reported using LPD compared to 
classical approaches like pLSA (Bicego et al, 2012). To alleviate these limitations 
and broaden the range of applications using LDA, we developed a novel 
transformation strategy using gene-ranking method to generate bag-of-words. 
 
The rationale behind this ranking is that relative ordering of gene 
expression is generally stable in a healthy human tissue but is largely disturbed 
in a diseased tissue. Within each sample, genes will be sorted in ascending order 
based on their expression values. Expression values form a distribution that will 
be divided into 20 bins. Actual expression values are then replaced with a 
quantized value (expression rank) based on its position. Value 1 indicates the 
group with the lowest expression level and value 20 indicates the group with the 
highest expression level. The combination of each gene with its corresponding 
expression rank (separated by a hyphen), generates a bag-of-words for each 
sample. For example, if gene BRCA1 was found in quantized bin 3 for a sample, 
the bag-of-words associated with that sample would include the word BRCA1-3 
to represent the ranked and quantized expression of this gene. It is important to 
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note that because of quantization, comparison between gene and word may not 
be absolute since one gene might represent many words across the samples. To 
extract gene-specific information from the LDA-derived model, it is thus 
necessary to develop a technique to reverse this one-to-many mapping to trace 
back genes from the corresponding words without deviating from the expression 
rank. 
 
To revert/collapse the genes from their corresponding words, expression 
rank and probabilities (of all words representing a gene) will be taken and 
normalized over the entire probability distribution (Equation 8) 
expg=∑j=1 rankgj*probgj /∑j=1 probgj             (8) 
where expg represents the collapsed expression rank of a gene g, j is the total 
number of words representing gene g. rankg ∈ (rankg1, rankg2, ...., rank gj) is a 
vector of rank extracted from words, and probg   ∈ (probg1, probg2, ...., probgj) is 
the vector of corresponding probabilities for the words.  
             Combining the topic-word probabilities in this manner results in a new 
topic-gene matrix, in which each topic is associated with a specific rank value for 
each gene. The resulting topic profile will facilitate subsequent classification. 
Thereby, ranking method will be able to capture the degree of deviation of gene 
expression across different samples and still enable gene interpretability of topics 
using topic profiles. 
Classification 
 
For each dataset, LDA was implemented using an open source Python 
library, Gensim (Rehurek, 2008). The LDA algorithm produces two matrices: the 
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topic-sample matrix, which expresses the computed probability of topics in a 
sample (document), and the topic-word matrix, containing the probability 
distribution over all available words for each topic. The LDA-derived matrices will 
be utilized to perform analysis as shown in Figure (4). 
Topic Analysis  
For testing, LDA-derived topic-sample and topic-word matrices from the 
trained model are employed. The new topic-gene matrix/ topic profile generated 
above, is used for subsequent classification. This novel approach to classification 
using LDA-based topic modeling differs from previous methods (Bicego et al., 
2010) where LDA is solely used as a feature extraction method and requires 
running LDA on both training and testing data. The approach proposed here 
applies the LDA algorithm only to the training data. Once the LDA model is 
trained, topic-word probabilities are used to assign topics to test data based on 
word occurrence using the maximum likelihood method. Topic assignments are 
then used to classify the testing sample. 
To classify a test sample based on the trained LDA, we need to determine 
topic probability distribution of the test sample. First, the same pre-processing 
step described earlier is applied to the test data, resulting in a bag-of-words 
based on ranked gene expression for each test sample. Then similarity (MSE) 
between testing data and each topic profile was calculated using Equation 9. The 
lower the MSE, the more similar is the topic. 
G  
M SE = ∑ (expg − bing )
2 
(9) 
g=1  
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Where expg represents the collapsed expression rank of gene g in a topic profile 
and bing represents expression rank of gene g in test sample.  
             Gaussian normalization was performed to reduce the range of the MSE, 
thus avoiding overflow errors in computation, without affecting the variation 
between topics and the softmax function (Equation 10) is applied to ensure that 
the probability distribution properly sums to 1.0 (Bishop, 2006). The probability 
distribution determined from similarity is used for prediction. 
Softmax output = k
esMSE , (10)    
∑ esMSE 
k=1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 Flowchart of the proposed approach 
Highlighted boxes represent the sequence of steps involved. Dashed lines divide 
the analysis into four groups: Training, Clustering, Classification and gene 
interpretation. Bar plots represent the topic distribution of samples 
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Clustering  
The LDA derived topic-sample matrix represents the degree to which each topic 
is expected to affect the word distribution in each sample. This topic-sample 
matrix was used for feature extraction/projection in a manner analogous to 
principal component analysis. Each column vector of the topic-sample matrix 
represents a single sample. There is one value in this vector for each topic, 
expressing the degree of association between the topic and the sample. Thus, if 
there are, e.g., three topics identified by the LDA algorithm, each column of the 
topic-sample matrix can be considered as a three-dimensional representation of 
the original sample. Complete-linkage and Euclidean-distance-based 
Hierarchical Clustering was applied on the topic-sample matrix to cluster the 
samples with similar probability distributions. 
 
Cluster purity and number of misclassified samples were calculated using 
Equation (11) to evaluate the clustering performance. 
k 
Purity = 1/N ∑ maxj|ci∩tj| (11)  
i=1 
 
Where N= number of data points, k= number of clusters, ci= a cluster in K, tj= 
classification that has the maximum count for cluster ci. 
           Cluster purity is an external validation metric to determine the quality of 
the clustering with respect to true labels in the data. The closer the cluster purity 
is to one, the more closely the observed clusters represent the known class 
divisions in the data. 
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Disease-Specific Genomic Analysis (DSGA) 
 
A Healthy State Model (HSM) was constructed from normal tissue data 
using FLAT construction (Botsch et al., 2007), a method to de-sparse the data in 
high dimensions by substituting for each normal tissue vector, its fit to a linear 
model in the other normal tissue vectors. For this, we use the Wold invariant 
(W(K)) (Eastmen and Krzanowski, 1982; Krzanowski and Kline, 1995; Wold, 
1978) designed to measure a version of signal to-noise ratio. We take k so that 
W(k) spikes up for the value k and construct the top k-dimensional principal 
component approximation of the flat normal data matrix. 
 
Linear models are then used to compute the fitted tumor data matrix to the 
HSM (normal component Nc.mat) and the residuals (disease component 
Dc.mat). Along with tumor data, a leave-one-out procedure gives an estimate of 
the deviation of normal tissue data from the model of the healthy state HSM. Two 
matrices are formed from the DSGA transformed data: Dc.mat, the disease 
component matrix, and L1.mat whose columns consist of leave-one-out 
estimates of the deviation from healthy state. We used Dcmat for our analysis. 
Mapper 
 
The Mapper algorithm was introduced by Singh, Mémoli and Carlsson as a 
geometrical tool to analyze and visualize datasets (G. Singh and Carlsson,1991). 
The power of Mapper method in TDA divides the data (high-dimensional dataset) 
into overlapping local clusters by a filter function and similarity between data 
 
38 
 
points, and then organizes them to create a low-dimensional graphical summary 
of the data. The idea behind Mapper is illustrated in Figure 5 and can be 
presented as follows: 
 
 
 
 
 
 
Figure 5 Representation of Mapper 
Mapper starts with a set of data points and a filter function and produces a 
colored graph that captures the shape of the data. This image of the function is 
subdivided into overlapping intervals and clustered separately. Each cluster is 
represented by a colored node (a bin of points). Pairs of bins that have points in 
common are connected by an edge. Copyright acknowledgement to Evaluating 
Ayasdi's Topological Data Analysis for Big Data, HKim2015. 
 
 
The first step is converting raw data into a point cloud data representing a 
shape, for example a circle using filter and metric. We color the circle by filter 
values and project on a coordinate to reduce complexity via dimensionality 
reduction. Filter function summarizes relevant information from noisy original 
data. Different filter functions summarize input data in different manners and 
multiple filters can be associated to build higher dimensional complex. Some 
examples of filter functions are gaussian density, PCA 1&2, mean, variance and 
Resolution 
 
Connection 
 
Clustering 
 
Filter & Metric 
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neighborhood lens 1&2. Some of the metrics are Cosine, Angle, Euclidean, 
Correlation and Hamming. 
 
The second step is defining a resolution for the range of partitioning and 
overlapping. Now, the point cloud data is covered with overlapping intervals and 
therefore it is broken into overlapping bins. 
The third step is clustering. We collapse the points in each bin into clusters 
using a clustering algorithm. Mapper uses any clustering algorithm from data 
mining to create nodes/ clusters. In other words, node is a clustered 
representation of group of data samples from the previous step. 
 
Finally, mapper constructs the output of topological network by 
referencing redundant data points where each node is represented by a vertex 
and an edge is drawn when there is non-empty intersection between clusters. If 
node contains no shared data sample, it remains as singleton. 
 
The final output of a mapper consists of multiple nodes and edges. A 
node can contain multiple samples and samples can appear in multiple nodes. 
The edge contains redundant data samples. Nodes are then colored by the 
average value of the filter function defined on the data points inside the node. 
Numeric values of these means are translated into colors just as numeric entries 
in a data matrix are turned into color to produce heat maps. Color ranges over 
red to blue where a red node contains data samples that have higher average 
values and a blue node contains lower average values. 
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IV. SPECIFIC AIMS 
 
 
 
Specific aim 1: Assess the effectiveness of Latent Dirichlet Allocation (LDA) in 
classifying tumor samples and healthy tissue samples using lung cancer and 
breast cancer gene expression data and identify known relevant 
features/biological pathways. 
 
Rationale 
 
Understanding the role of differential gene expression in the development 
of and molecular response to cancer is a complex problem that remains 
challenging, in part due to the sheer number of genes, gene products, and 
metabolites involved. While, datasets involving a few variables are easily 
analyzed through simple visualizations and classification methods, large and 
complex data sets, which are high-dimensional gene expression data, for 
example, are difficult to analyze through conventional means. Such analysis of 
high-dimensional data is best accomplished through use of techniques which 
mitigate overfitting and develop a high-level understanding of the associated 
genes. In this aim, we develop a novel approach to classification of cancer and 
normal samples using LDA-based topic modeling and explore the effectiveness 
of the method in distinguishing gene expression patterns in cancer tissues 
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from those in normal tissue. For each dataset, LDA was implemented using an 
open-source Python library to produce topic profiles for the training data using 
the protocol and parameters shown in Figure (4). 
 
Method  
          To determine an effective method for converting gene expression data into 
text and vice-versa, we compared our gene expression transformation (gene-
ranking) which is described in detail in Material and Methods with other bag-of-
words transformation methods from the literature.  
 
For comparison, we explored repetition approach and previously 
implemented median-value approach (Zhao et al. 2014). The median-value 
approach is the most commonly used transformation method that transforms 
expression values into 0 (lower than median) or 1 (higher than median) 
respectively. Within each sample, only the gene that has transformed value 1 is 
treated as a word and occurs once in the bag-of-words. Whereas, for the 
repetition approach, the gene expression matrix is scaled to discrete values and 
those values are then interpreted as gene/word occurrences. To scale, gene 
expression values will be sorted in ascending order and divided into 20 bins. 
Each gene is treated as a word, and its occurrence is repeated based on which 
bin it has been assigned. For instance, if gene BRCA1 was found in quantized 
bin 3 for a sample, the word ‘BRCA1’ would be repeated three times in that bag-
of-words.  
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           To determine the ideal number of topics and iterations for classification of 
gene expression data from lung cancer and breast cancer datasets, parameter 
search was performed by running the LDA algorithm on breast cancer gene 
expression data with fixed number of topics (2, 3, 5, 10, 20 and 30,), fixed 
number of passes (1, 2, 5, 10, 20, 50 and 100,) and fixed number of bins (5, 10, 
20, 30 and 40). Optimum parameters were inferred using the classification 
approach described in Materials and Methods considering both the 
computational time and performance. 
The performance of our classification approach was compared with 
popular supervised methods including SVM, Naive Bayes and Random Forest 
classifiers using 10-fold cross validation. Traditional metrics for comparison like 
accuracy, precision, recall and F-measure were applied. Similarly, the clustering 
result from LDA was compared with other conventional clustering and projection 
methods including hierarchical clustering and principal component analysis 
(PCA). Hierarchical clustering was directly applied to the raw expression values 
for breast cancer (23424 genes) and lung cancer (23996 genes). PCA was first 
used to transform the original data into components that retain 90% of the 
variance. Hierarchical clustering was then applied on the transformed data. For 
both datasets, cluster purity and number of misclassified samples were 
calculated using Equation (8) to evaluate the clustering performance. 
In addition to diagnostic application, a key objective for feature selection 
and classification of expression data in cancer tissues is the identification of 
differential expression patterns that may help to understand the etiology of and/or 
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molecular responses to specific cancers. Here, we utilized topic profiles from the 
two data sets to perform pathway analysis and disease annotation of differentially 
expressed genes within each topic. A list of differentially expressed genes 
(DEGs) is extracted by computing the difference in expression rank of each topic 
with a baseline. For the experiments shown here, topic 3 was chosen as the 
baseline in both breast cancer and lung cancer datasets, since it shows the 
highest probability in normal samples (Figures 8 and 9). Differentially expressed 
genes were then identified from all other topics (1 and 2 in this case). A threshold 
rank-difference of 5 was used to extract the significant genes and limit the 
number of genes for further analysis. Thus, the extracted genes have at least 5 
ranking changes between normal and tumor that could potentially represent 
significant dysregulation in our analysis. 
Further, we examined the pathway enrichment of the differentially 
expressed genes using DAVID Bioinformatics Resources 6.8 
(https://david.ncifcrf.gov/home.jsp) (Dennis et al. 2003) to explore the KEGG 
pathway database. Figures 10 and 11 show the number of genes and statistically 
enriched pathways in the topics for breast cancer and lung cancer, respectively. 
The relevance of the identified differentially expressed genes was validated using 
the DAVID bioinformatics suite (Dennis et al. 2003) and the NIH genetic 
association database (GAD) (Becker et al. 2004). The differentially expressed 
genes were extracted by comparing the expression profile for normal and tumor 
samples, which were generated using the procedure described below. For each 
gene, its expression rank (expg) in topic profile matrix (~24000x3) was multiplied 
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with respective topic probability distribution of normal group (3x1) and tumor 
group (3x1). This would generate two expression profiles: one for normal 
samples (~24000 x 1) and one for tumor samples (~24000 x 1). The difference in 
expression rank between these two profiles was computed. Using the threshold 
of 5, a list of differentially expressed genes was extracted both for breast cancer 
and lung cancer and annotated using DAVID Bioinformatics Resources 6.8 in 
terms of GAD disease. 
Results  
Three different sets of bag-of-words were generated using the three 
transformation approaches and were used as input for LDA algorithms, using 
parameters determined as described below. The topic probability distributions for 
both classes generated by these three approaches are shown in Figure 6. The 
repetition approach yielded highly similar topic probability distributions for normal 
and cancer tissues. Both the median and ranking approaches effectively 
generated distinctive topic probability distributions for each class.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 Data transformation approaches 
Topic probability distribution of breast carcinoma samples for (a) repetition 
approach, (b) median approach and (c) ranking approach. Bar plots represent 
topic-sample probability for the 3 topics identified by LDA. 
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     As shown in Figure 7 (c), 1, 2 and 10 passes achieved the highest F-measure 
in the classification task. As shown in Figure 7 (b), utilizing five topics achieved 
the highest F-measure (0.978), while limiting the number of topics to three 
achieved a comparable performance (0.977). The performance of the algorithm 
is robust relative to bin size (5, 10, 20, 30, 40 bins). 
  
Figure 7 Parameter Selection. 
Comparison of F-measure, accuracy, sensitivity, and specificity with varying 
number of a) bins, b) topics and c) passes  
 
 
Table 1 Classification results of our proposed approach and three 
supervised algorithms: SVM, Naive Bayes, and Random Forest 
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Figure 8 Topic probability distribution and hierarchical clustering for breast 
cancer data 
a) Topic probability distribution and b) Hierarchical clustering of samples using 
derived topic probability for breast carcinoma. Bar plots represent average topic-
sample probability for the 3 topics. Heat map shows the clustering of samples 
into two classes. 
 
 
 
Figure 9 Topic probability distribution and hierarchical clustering for lung 
cancer data 
a) Topic probability distribution and b) Hierarchical clustering of samples using 
derived topic probability for lung cancer. Bar plots represent average topic-
sample probability for the 3 topics. Heat map shows the clustering of samples 
into two classes. 
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    A very clear separation in topics between the two classes was observed for 
both breast cancer and lung cancer data (Figures 8, 9). As shown in table 1, LDA 
achieves a competitive performance comparable to other algorithms. Table 2 
shows the clustering results of the three methods where the number of clusters 
(K) is fixed at 2, 3, and 4 clusters. Overall, LDA clusters align more closely to 
known cancer/healthy tissue labels than those obtained by PCA and Hierarchical 
Clustering. 
 
 
Table 2 Clustering results of LDA-derived topic probabilities, 
PCA reduced features, and Hierarchical Clustering 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
             Table 3 shows the top 5 highly related diseases which are ranked 
ascendingly according to their p-value. As expected, for the gene list extracted 
from breast cancer data corpus, ‘breast cancer’ is the disease with highest 
enrichment (lowest p-value) and for lung cancer data corpus, it is ‘smoking 
cessation’. 
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Discussion  
         While both ranking approach and median approach generated distinctive 
topics between the two classes, we chose ranking approach for further analysis 
because of the following reasons. One drawback to median approach is that it 
requires test samples be transformed along with training samples, which affect 
the generation of the bag-of-words to train the LDA algorithm. In other words, the 
whole preprocessing step and LDA algorithm must be performed every time a 
new test sample is given. Furthermore, preprocessing using the median may risk 
having a batch effect, handling both test data and training data separately which 
would require another normalization before transformation. The ranking 
approach, on the other hand, does not suffer from such an effect and does not 
require normalization (Wang et al.) 
We chose 10 passes, as it performed better clustering and did not incur 
much increase in computational time (not shown). Performance gains with further 
increases in the number of topics were limited, and performance begins to 
degrade with more than 10 topics. Most importantly, the computational time for 
training LDA on gene expression data increases linearly with the number of 
topics. Therefore, we selected 10 passes and 3 topics as the most effective 
combination for training LDA on our gene expression data. The number of bins 
represents the relative ranking of expression level instead of absolute ranking 
and hence the observed phenomenon (Figure 7 (a)). We chose 20 bins as a 
representative of the performed experiments. While this selection strategy could  
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Figure 10 Functional annotation of dysregulated genes in breast cancer.  
Venn diagram of differentially expressed genes in Topic 1, in Topic 2 for breast 
Cancer. Tables represent the affected pathways for each subset of genes, and 
their adjusted p-value. The lower the adjusted p-value, the higher the significance 
of the pathway. 
 
 
 
 
 
Figure 11 Functional annotation of dysregulated genes in lung cancer.  
Venn diagram of differentially expressed genes in Topic 1, in Topic 2 for Lung 
Cancer. Tables represent the affected pathways for each subset of genes, and 
their adjusted p-value. The lower the adjusted p-value, the higher the significance 
of the pathway. 
 
 
 T1
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Table 3 Top 5 related diseases from breast cancer and lung 
cancer disease annotation 
 
 
 
be effective for most gene expression datasets, it may not be suitable for variant 
analysis because of the nature of the data where gene expression data presents 
a dynamic range. 
One advantage of LDA-based clustering for gene expression data may be 
its mutually non-exclusive assumption. Most non-fuzzy clustering approaches 
have a mutually exclusive/independence assumption that a sample/gene is 
restricted to only one cluster. This assumption might not be logical for gene 
expression data largely when a sample/gene share characteristic with more than 
one cluster (that is one gene can be involved in different pathways/ biological 
process). Thus, using LDA for clustering of genomic data would reflect the 
complex interplay between genes and pathways and improve quality of the 
results. 
Gene interpretation using our approach derives significant pathways in both 
breast cancer and lung cancer data. The interpretation of differentially expressed 
genes depends on sample topic probability between classes. In breast cancer 
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data, using the same threshold, more differentially expressed genes are 
extracted from Topic 1 compared to Topic 2. This is since Topic 2 predominantly 
contains normal sample (Figure 7(a)). Thus, most annotated pathways from 
Topic 1 are significantly related to cancer such as PPAR signaling pathway, p53 
signaling pathway and AMPK signaling pathway. However, in lung cancer data, 
Topic 3 is the only normal topic whereas both Topic 1 and Topic 2 are cancer-
related topics (Figure 8(a)). Thus, there is a huge overlap of differentially 
expressed genes between these two topics. Some of the significant pathways 
identified from this overlap are p53 signaling pathway, PI3K-Akt signaling 
pathway, and Ras signaling pathway. 
 
 
Specific Aim 2 Determine the effectiveness of LDA to classify different subtypes 
of breast cancer and to identify the appropriate genes associated with specific 
subtype. 
 
Rationale 
 
Breast cancer is a heterogeneous complex of diseases, a spectrum of many 
subtypes with distinct biological features that lead to differences in response to 
various treatment modalities and clinical outcomes. It is therefore necessary to 
devise a clinically meaningful classification of the disease specific subtypes to 
ensure the best possible patient response to therapy. The challenge is to extract 
a minimal optimal set of genes with good prognostic properties from a large bulk 
of genes making a moderate contribution to classification. In recent years, 
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various machine learning methods were applied to extract a subset of genes 
allowing for robust classification of subtypes, including support vector machines 
(Shieh et al., 2004) and random forests (Guan et al., 2012). Different gene sets 
and methods for the identification of the breast cancer subtypes have been 
published, outcome of these different methods/gene lists only show a modest 
agreement and may assign the same patient to different intrinsic subtypes 
(Mackay et al., 2010, Pineda et al., 2015). It has been suggested, however, that 
technical limitations such as data normalization and platform annotation may 
have reduced the accuracy in subtype predictions (Perou et al., 2010, Ellis et al., 
2012). 
 
In this aim, the focus is on identifying a classification approach that can 
reliably predict each of the breast cancer subtypes using gene expression 
information. In this context, we develop a novel classification framework using 
LDA with a feature selection strategy using DSGA, and we apply it to the 
classification of breast cancer subtypes. Hoping that the shape of the point cloud 
given by columns of patients with rows of genomic variables would give some 
insight on how the types of breast cancers should be grouped, topological based 
analysis was also used on the same data. 
Method 
 
        To compare classification accuracy of LDA-based classifier using breast 
cancer gene expression data corresponding to tumor subtypes and with other 
machine learning approaches, we applied the classification strategy defined in 
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the Materials and Methods to breast cancer gene expression data. Classification 
accuracy and F-measure were measured and compared with support vector 
machine and Naive Bayes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                          
 
 
 
 
Figure 12 The wold invariant plot for Breast cancer subtype data 
Graph is plotted as a function of the dimension reduction K 
 
   We further applied feature engineering using DSGA where data from both 
tumors and normal tissue were combined, and the Healthy State Model (HSM) 
was constructed from normal tissue data using FLAT construction and principal 
component analysis. Figure 12 plots W(k) vs. the dimension k and shows a jump 
at k = 7, indicating that signal-to-noise ratio is higher at dimension 7, thereby 
justifying PCA dimension reduction of the FLAT normal data to 7-dimensional 
HSM. Based on HSM, each tumor tissue is decomposed as the sum of two 
components: (i) the normal component, its linear model fit to the HSM; (ii) the 
disease component, vector of residuals, assessing the extent to which each 
W(K) 
 
Dimension of PC space = K 
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tumor deviates from the normal state. The disease component was used for the 
identification of the molecular subtypes yielding 270 unique genes. 
 
Further, LDA was applied on the DSGA transformed data and 
classification accuracy and topic distribution were recorded. Additionally, we 
applied TDA to the raw data and DSGA-transformed data matrix to visualize the 
distribution of data. Mapper filter functions were calculated for the following 
parameters: metric = Euclidean (L2), filter = Neighborhood lens 1 & 2, resolution 
= 30 and gain = 2.50. It should be noted that multiple outputs can be constructed 
by applying all possible combination of metrics and filters. To decrease 
information redundancy, we based our selection on the domain knowledge of 
gene expression profiling. In this domain, relative expression values among the 
genes or probes are valuable to conserve meaningful information more than 
absolute gene expression levels. Thus, we selected a metric that can measure 
the distance of numerical data points and some of the relevant metrics are 
Cosine, Angle, Correlation or Euclidean. Euclidean metric was chosen because it 
is least computationally expensive and will be a good starting point for the current 
research. Similarly, neighborhood lens 1&2 can be categorized as a projection 
filter to magnify distance between the groups. It generates a two-dimensional 
embedding of the k-nearest neighbor graph by connecting point to its nearest 
neighbors. 
           To identify the ability of LDA in finding known biological pathways that are 
functionally related to breast cancer, we utilized topic profiles from the subtype 
data to perform pathway analysis and disease annotation of differentially 
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expressed genes within each topic. A list of differentially expressed genes 
(DEGs) is extracted by computing the difference in expression rank of each topic 
with a baseline. Differentially expressed genes were then identified from all other 
topics. A threshold rank-difference of 5 was used to extract the significant genes 
and limit the number of genes for further analysis. Thus, the extracted genes 
have at least 5 ranking changes between the different subtypes that could 
potentially represent significant dysregulation in our analysis. We used DAVID 
and GAD to identify differentially expressed genes that associate with specific 
subtypes of breast cancer. 
 
Figure 13 Topic probability distribution of breast cancer gene expression 
data into subtypes. 
 Bar plots represent average topic-sample probability of the 5 topics for 5 
different subtypes: Basal, HER2, Luminal A, Luminal B and Normal-like 
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Figure 14 Topic probability distribution of breast cancer gene expression 
samples into subtypes after DSGA transformation. 
 Bar plots represent average topic-sample probability of the 8 topics for 5 
different subtypes: Basal, HER2, Luminal A, Luminal B and Normal-like. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15 Mapper output for Breast cancer gene expression data before 
DSGA (ER+/-).  
The output displays ER+ samples (red bins). Each bin is colored by the mean of 
the filter map on the points. Blue bins contain tumors whose total deviation from 
HSM is small (normal and Normal-like tumors). Red bins contain tumors whose 
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deviation from HSM is large.  White bins indicate the rest of the samples. Several 
bins (singletons) are disconnected from the main graph. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16 Mapper output for Breast cancer gene expression data after 
DSGA (ER+/-).  
The output displays ER+ (red bins). Each bin is colored by the mean of the filter 
map on the points. Blue bins contain tumors whose total deviation from HSM is 
small (normal and Normal-like tumors). Red bins contain tumors whose deviation 
from HSM is large. White bins indicate the rest of the samples. Several bins 
(singletons) are disconnected from the main graph. 
 
 
Results 
 
    Figure (13) shows the LDA topic distribution of 295 samples and 18,970 
genes for all 5 breast cancer subtypes. LDA on raw data however did not result 
in good topic separation and accuracy. In this case, we considered doing a 
feature reduction (DSGA) that was proven to improve the performance of the 
model. DSGA transformation produced a data matrix of 295 samples and 260 
genes. Figure (14) shows the LDA topic distribution on the DSGA transformed 
data. The performance of our classification approach was compared with popular 
supervised methods including SVM, Naive Bayes and Random Forest classifiers 
using 10-fold cross validation. Traditional metrics for comparison like accuracy, 
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precision, recall and F-measure were applied. Table 4 presents classification 
accuracy of our model compared to other classifiers. As revealed by the p-values 
of the t-test, the proposed model competes on-par with SVM and Random Forest 
in classifying ER, Basal and Lum B and outperforms in classifying all classes, 
HER2, Normal-like and Lum B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 Mapper output for Breast cancer gene expression data after 
DSGA (basal). 
The output displays basal subtype (red bins). Each bin is colored by the mean of 
the filter map on the points. Blue bins contain tumors whose total deviation from 
HSM is small (normal and Normal-like tumors). Red bins contain tumors whose 
deviation from HSM is large.  White bins indicate the rest of the samples. Several 
bins (singletons) are disconnected from the main graph.  
 
              Figures 15 and 16 shows the outputs of mapper before and after DSGA 
transformation with red nodes denoting ER+ bins. Each node is a bin of tumors, 
and its color encodes the value of the filter function averaged across all the data 
points in the bin, with blue denoting a low value and red encoding a large value. 
Thus, bins that are blue contain tumors whose expression is close to normal, 
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whereas bins that are red contain tumors that generally have large deviation from 
normal along multiple genes, in both the positive and the negative direction.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 Mapper output for Breast cancer gene expression data after 
DSGA (normal-like) 
The output displays normal-like. Each bin is colored by the mean of the filter map 
on the points. Blue bins contain tumors whose total deviation from HSM is small 
(normal and Normal-like tumors). Red bins contain tumors whose deviation from 
HSM is large.  White bins indicate the rest of the samples. Several bins 
(singletons) are disconnected from the main graph.  
 
            There are several groups of tumors that stand out. Basal tumors occupy 
most of the bins in the tumor sequence denoted as ER− sequence (Figure 17). 
They are immediately visible and stand out with large value (red) in the filter 
function: overall deviation from normal. Normal-like tissue samples (Figure 18) all 
fall in the same bin together with 3 additional ER+ tumors. These are colored 
blue and show minimal overall deviation from normal according to the filter 
function. Luminal A group (Figure 19) occupies most of the bins in ER+ sequence 
owing to the well-understood characteristic that all Luminal A subtype are ER+. 
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Figure 19 Mapper output for Breast cancer gene expression data after 
DSGA (Luminal A/B)  
The output displays Luminal A/B subtype. Each bin is colored by the mean of the 
filter map on the points. Red bins indicate Luminal A tumors and green bins are 
Luminal B.  White bins indicate the rest of the samples. Several bins (singletons) 
are disconnected from the main graph. 
 
 
Figure 20 Mapper output for Breast cancer gene expression data after 
DSGA (HER2+) 
The output displays HER2 subtype (red bins). Each bin is colored by the mean of 
the filter map on the points. White bins indicate the rest of the samples. Several 
bins (singletons) are disconnected from the main graph. 
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An additional long tumor sequence on the graph, HER2 showing large 
deviation from normal is visible between ER+ and ER- sequence, as defined by 
the filter (Figure 20). This group also consists of ER+ tumors supporting the 
observation that nearly half of HER2-positive is ER+ but with lower expression 
levels of ER (Creighton et al., 2012). Another work from Perou et al., 2012 stated 
that luminal B might represent the ER+/HER+ form of breast cancer; however, 
HER2 gene does not show high levels in luminal B. As expected and in 
agreement with the above statement, a small subset of HER2 tumors in the 
above sequence are assigned to luminal B (Figure 20). LDA-DSGA classification 
in agreement with mapper results also produced distinct topic distribution of 
breast cancer subtypes (Figure 14). 
 
 
Table 4 Classification results of DSGA transformed breast cancer  
gene expression data using LDA, SVM, and Random Forest. 
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        We extracted unique genes after DSGA transformation, only differentially 
expressed genes within each topic were extracted between the subtypes. A 
threshold rank difference of 7 was used to extract the significant genes and 
pathway analysis results were observed.  
 
We found 120 genes in common among the subtypes. Specific genes for 
each subtype are 16 DEG’s for luminal A, 24 for luminal B, 33 for HER2, 58 for 
basal and 19 for normal-like. Furthermore, we detected 23 pathways in common 
among the subtypes. We detected pathways specific for each subtype in this 
proportion: 10 for luminal A, 5 for luminal B, 6 for HER2, 8 for basal and 3 for 
normal-like. Table 5 represents the pathways associated with specific subtypes. 
 
10 specific pathways were identified in Luminal A, some among them are 
prothrombin pathway and ethanol oxidation. Prothrombin Pathway plays an 
essential role in coagulation, a crucial step for metastasis in cancer (Lima et al., 
2013). The pathway of ethanol oxidation contains several genes belonging to the 
family of ALDH and that, despite their known role in ethanol detoxification, are 
also considered biomarkers of cancer stem cells (Marcato et al, 2011). 
 
We identified 5 specific pathways in luminal B including cell cycle pathway 
and cell junction pathway. Cell junctions are necessary for cell-cell adhesion 
machinery related to the differentiation and normal growth of the tissue (Alberts 
et al., 2002). The progression of cancer represents a modification of normal 
tissue homeostasis and an alteration in cell-cell interaction. In addition, Bendas 
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et al. 2012 reported that cancer metastasis spreads through the circulatory 
system caused by cell adhesion. 
 
Table 5 Functional annotation of differentially expressed genes in breast 
cancer subtypes 
 
 
We identified 8 specific pathways in basal-like including amino acid 
synthesis and metabolism of amino acids. It has been shown that deregulated 
amino acid metabolism has a function in immune tolerance in cancer (Nagarajan 
et al., 2016). 6 specific pathways were identified in HER2 including axon 
guidance. Axon guidance pathway includes four families of secreted or 
membrane bound factors (i.e., netrin 1, semaphorin, ephrins, and Slit, along with 
their receptors), which have recently studied as central agents in tumor 
progression. 
 
 
Discussion 
 
   Separation of topics between subtypes using LDA alone was not successful. 
This is likely because of overlapping among different breast cancer subtypes 
considering some special types of breast cancers: for example, some basal-like 
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breast cancers (molecular classification) will not show the expected triple-
negative (ER, PR and HER2 negative from immunohistochemistry) and some 
HER2 positive tumors are assigned to lum-B. Furthermore, because of the large 
number of features used by microarray data sets, there is redundancy of 
information. However, feature reduction using DSGA significantly improved the 
topic separation between subtypes. 
 
Comparison of the LDA clustering results before and after DSGA 
transformation, the Normal-like tumor group (topic 3) is often observed through 
both types of analysis. However, the other groups, HER2, basal and luminal 
tumor groups were scattered across several topics, as seen in Figure (13). Thus, 
unlike DSGA-LDA analysis, cluster analysis solely based on LDA was unable to 
identify subtypes of breast cancer. This shows that the appearance of the tumor 
subtypes was due to the way data were transformed via DSGA to identify subtle 
shape characteristics of the data set. Topic distribution of raw data scattered the 
tumors in the ER+ tumor progression and even the very tight basal tumor group. 
Thus, a combination of LDA and DSGA is well suited for this type of analysis. 
 
         Additionally, DSGA followed by Mapper analysis revealed the topological 
connections among samples as a function of the gene-expression data and it 
was found that the five molecular subtypes summarize the continuous 
progression from samples closer (in the ER+ and luminal A subtypes) to samples 
distant (in the Basal and HER2 subtypes) to the normal state. It is likely that the 
adoption of the proposed analysis based on LDA-DSGA may help to overcome 
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some of the limitations of the previous approaches and prove to be effective in 
informing the selection of genes. Furthermore, it does not ignore the precise 
identification of morphologically identifiable ‘special’ types of breast cancer, 
whose clinical outcome may be strikingly different from that of the other members 
of the same class and justifies a different therapeutic option. 
The inherent heterogeneity in human breast cancer presents an enormous 
challenge for predicting significant pathways and for understanding mechanism 
of the disease. This could explain the overlap we observe in the associated 
genes and pathways between the subtypes. Nonetheless, our classification 
scheme was able to identify some interesting patterns in the gene regulation 
between the subtypes. Although these results are important in differentiating the 
molecular subtypes of breast cancer, it is critical to validate these further for 
clinical applications. Developing a pathway/gene signature based on the 
presented results as the basis for tumor classification would be the immediate 
step along these lines. 
 
Specific Aim 3 Assess the effectiveness of LDA in classifying skin 
cutaneous melanoma from benign nevi using copy number data and to 
identify known melanoma related genes. 
 
Rationale 
 
Due to the high skin cancer incidence and mortality rates, early diagnosis of 
melanoma has become an extremely important issue. Here, we present a new 
approach to the classification of melanocytic lesions. Most of the research done 
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so far in this area has concentrated on creating new methods to distinguish 
benign from malignant skin lesions. In our research we go one step further and 
differentiate melanocytic lesions like melanocytic nevi, and malignant melanoma. 
 
Some tumors have ambiguous histopathological features that overlap 
between melanocytic nevi and melanoma. Therefore, the pathology of 
melanocytic nevi remains one of the most challenging and controversial areas in 
diagnostic histopathology. Although molecular diagnostic techniques have shown 
some promise in differential diagnosis of melanoma, emergence of comparative 
genomic hybridization that can screen entire genome for copy number changes 
have become popular in distinguishing melanoma from nevi. Several studies 
have revealed that most melanomas differ from nevi in their genetic makeup 
(Bastian et al., 2003). These fundamental studies established the fact that 
genetic factors/copy number can be valuable for histopathologically ambiguous 
melanomas. In this aim, we use LDA and DSGA to build and test classification 
models, compare the different techniques based on their classification 
performance and identify the genes/copy number variations that distinguish the 
two classes. 
 
Method 
Prior to classification, data was preprocessed to convert copy number data 
to text. Different transformation approaches like ranking and threshold based 
(methods section) were tested and the best performing technique. For ranking, 
within each sample, genes were sorted in ascending order based on their copy 
number values and the distribution is divided into 5 bins. Copy number 
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segmentation threshold was also used to convert the copy number calls into 
gain, normal and loss. Based on the segmented copy number data from copy 
number inference pipeline, we customized the amplification and deletion 
threshold for log2 ratios to >0.1 and < -0.3, respectively. When transforming the 
copy number data to text, genes within the segments that contain log2 ratio 
above 0.1 are labeled as G (gain) and the ones that have a log2 ratio of less than 
-0.3 are labeled as L (loss), respectively. Any other value of log2 ratio is labeled 
as N (normal). 
 
LDA based classification approach was applied to copy number data from 
skin cutaneous melanoma as discussed earlier and compare the performance 
accuracies with other classifiers. For cross validation testing of the model, we 
used 10-fold cross validation. Complete-linkage and Euclidean-distance based 
hierarchical clustering was applied on the topic-sample matrix to cluster the 
samples with similar probability distributions. Later, DSGA was applied to the raw 
data resulting in a data matrix of 64 samples and 3300 genes. Dimension 
reduction using W (k) shows a jump at k = 7 and this produced the 7-dimensional 
HSM (Figure 24). Based on HSM, each tumor tissue is decomposed, and the 
resulting disease component matrix is used for classification. 
 
Data was visualized in mapper using the correlation metric. Copy number 
data extracted from FFPE samples is expected to be extremely noisy and unlike 
the gene expression data, is not dynamic in nature. Correlation metric normalizes 
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the columns to become comparable and hence is used. Neighborhood 1&2 are 
selected to project into a 2-dimensional space. 
          We used DAVID and GAD to identify differentially expressed genes that 
associate with melanoma and nevi. Here, topic profiles from the datasets were 
utilized to perform pathway analysis and disease annotation of differentially 
expressed genes (DEGs) within each topic. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21 Topic probability distribution and Hierarchical clustering of 
melanoma copy number data before DSGA. 
 Bar plots represent average topic-sample probability for the 3 topics. Heat map 
shows the clustering of samples into two classes 
 
Results  
         Comparing the topic probability distribution for both classes generated by 
both approaches, threshold-based transformation performed significantly better 
in terms of topic distribution and accuracy (Figure 21). For rank-based, the 
separation in topics between melanoma and nevi was not significant. Better topic 
distribution using copy number threshold can be attributed to the nature of the 
data. Since the number of bins represents the relative ranking of copy number 
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instead of absolute ranking, it was more suitable for gene expression data rather 
than the discrete copy number data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 22 Topic probability distribution and Hierarchical clustering of 
melanoma copy number data before DSGA. 
 Bar plots represent average topic-sample probability for the 3 topics. Heat map 
shows the clustering of samples into two classes. 
 
 
 
Figure 23 The wold invariant plot for melanoma copy number data 
  
Graph plots goodness of fit measure W(k) versus the number of dimensions K to 
determine correct dimension reduction for PCA. 
Dimension of PC space = K 
 
W (K) 
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Comparison of the model performance using the cross validated model 
accuracy indicate that while all the three models SVM, RF and LDA along with 
DSGA were very highly accurate, RF+DSGA had the best performance albeit 
only by a very small margin. The heat map in figures 22 and 23 shows that for 
both analysis before and after DSGA, samples were grouped into two classes, 
melanoma and nevi with good separation associated with the latter. Similarly, 
comparing LDA performance before and after DSGA transformation, LDA after 
transformation outperformed the other. Owing to the large number of variables 
(24000) and small sample size (64), using LDA alone on the raw data did not 
improve accuracy compared to other approaches. Visualization of the results 
using mapper indicates that feature reduction using DSGA significantly improved 
classification performance of LDA. DSGA transformation mostly separates the 
malignant melanoma from the rest of the melanocytic nevi data.  
 
  
            Table 6 shows the top 5 highly related diseases which are ranked 
ascendingly according to their p-value. As expected, for the gene list extracted 
from copy number data corpus, ‘Melanoma’ is the disease with highest 
enrichment (lowest p-value). 
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Figure 24 Mapper output for melanoma copy number data before DSGA 
The output displays melanoma samples (red bins). Each bin is colored by the 
mean of the filter map on the points. Blue bins contain tumors whose total 
deviation from HSM is small. Red bins contain tumors whose deviation from HSM 
is large.  White bins indicate the rest of the samples. Several bins (singletons) 
are disconnected from the main graph.  
 
Discussion 
 
          While both clustering results before and after DSGA (figures 22 and 23) 
only partially separated samples between melanoma and nevi, the separation 
was significant after DSGA. The very high accuracy achieved by all the three 
models after DSGA transformation implies is due to the way, data were 
transformed by DSGA. The high accuracy is also likely due to the relatively less 
number of variables. Comparison of model performances using accuracy after 
cross validation indicated the LDA+DSGA had the best performance. This 
observation, in combination with the results of the other sub aims, further 
validates the idea that a very high classification performance can be achieved 
when DSGA precedes the standard classification approaches. 
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Figure 25 Mapper output for melanoma copy number data after DSGA  
The output displays melanoma samples (red bins). Each bin is colored by the 
mean of the filter map on the points. Blue bins contain tumors whose total 
deviation from HSM is small. Red bins contain tumors whose deviation from HSM 
is large.  White bins indicate the rest of the samples. Several bins (singletons) 
are disconnected from the main graph. 
 
 
Table 6 Classification results of DSGA transformed melanoma copy 
number data using LDA, SVM, and Random Forest 
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       Although, with this dataset, SVM was only slightly behind LDA and RF 
achieved little over in terms of classification performance. Even if we are 
comparable with the state of art methods, we can be another contributor to the 
ensemble methods. 
 
  An interesting observation to note is the visualization of the mapper plot 
before and after transformation. While the earlier did show some separation 
between the two sample groups, the latter separated melanoma entirely from the 
rest of the cumulative dataset. Also, interesting to note is the fact that despite the 
singletons in the mapper plot, clustering of melanoma samples after 
transformation can be labeled as the tightest group in the plot. The difference is 
likely because of the redundancy of the genes before and after transformation, 
where the latter corresponds to only disease-relevant data deviating from the 
nevi. It is important to indicate that the parameters used to visualize the two plots 
are very similar as indicated above and hence justifying the comparison between 
these two. 
 
Some of the significant genes in the identified genomic regions from this 
analysis are listed here: MCM10, CDKN2A, RAD51, IL9, CDK1, BCL2A1, IL13, 
MAPK9, WNT2, CCL3 and myc. With regards to pathways associated with 
variant genes between melanoma and nevi, calcium signaling, and olfactory 
transduction being identified as the two top pathways is not surprising when 
considering their functional role in driving melanoma. Regulation of intracellular 
Ca2+ has an important impact on melanoma growth and metastasis. Significance 
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of Olfactory transduction agrees with several reports that claim that most of the 
cancer cell lines expressing olfactory receptors express the effectors necessary 
for OR-mediated signal transduction. Another recent finding by Ranzani et al., 
(2017) confirmed the expression of OR2C3 gene that encodes olfactory receptor 
2C3 protein, in human melanomas but not in normal melanocytes. 
 
Table 7 Functional annotation of differentially 
 expressed genes in melanoma 
 
 
Many of the enriched pathways are closely associated with tumorigenesis 
and metastasis. In particular, the Wnt/ β-catenin pathway is associated with Wnt 
signaling which regulates many genes implicated in melanoma. Deregulation of 
the Wnt-related pathways reportedly affects melanoma proliferation and 
differentiation (Jeff et al, 2013, Chien et al, 2009). 
The application of DSGA for the first time to copy number data other than 
gene expression data enabled the description of a robust copy number-based 
melanoma/nevi classification. To confirm the pathological relevance of the 
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extracted genes, we analyzed the functional correlation of the genes using 
disease annotation and the diseases identified by the model are indeed 
consistent with melanoma/skin cancer. The clear separation between before-
DSGA and after-DSGA samples in both analysis imply that the genes after the 
feature reduction significantly played a role. Also, the fact that melanoma 
samples clustered after-DSGA indicates that the genes after the feature 
reduction closely associated with melanoma and hence melanoma is listed as 
top1 disease. 
 
 
Table 8 Functional annotation of differentially 
expressed genes in melanoma 
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Table 9 Top 5 related diseases from melanoma vs nevi  
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V. SUMMARY AND CONCLUSION 
 
The analysis of microarrays and next generation sequencing has become 
one of the main research areas in computational biology, and new methods and 
applications are continuously being developed. Here, we have reviewed 
limitations of current statistical and machine learning methods and how Latent 
Dirichlet Allocation could overcome these limitations. 
 
Many approaches to diagnostic classification based on mRNA expression 
focus primarily on differential expression. The LDA-based approach described 
here differs in that the focus is primarily on co-expression. Just as textual LDA 
attempts to group co-occurring words into topics to explain the topic composition 
of a document, gene expression LDA can be used to identify co-regulated groups 
of genes that together explain the overall patterns of gene expression in healthy 
and disease states. In an unsupervised mode, this technique has shown a 
somewhat surprising ability to produce gene-collections (topics) that differ 
significantly between cancer and healthy tissues. 
 
Specific aim conclusions 
 
Specific aim 1  
In both breast cancer and lung cancer gene expression data sets, LDA  
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successfully classified tumor samples from normal with high accuracy and 
identified relevant biological features/pathways. Some of the observations are 
 
• Ranking method was found to be effective compared to other methods for 
converting gene expression data into text and vice-versa. 
• Choosing 3 topics, 10 iterations and 20 bins for LDA were determined 
ideal for classification of tumor samples from normal samples based on 
gene expression data in both breast cancer and lung cancer data. 
 
• LDA approach was proved to be effective compared to other state-of-art 
machine learning classification methods in terms of classifying breast 
cancer and lung cancer data from normal data. 
 
• LDA classification model was able to successfully identify known related 
genes/pathways that contributed the most to differences in gene 
expression profiling between tumor and normal samples. 
 
 
Specific aim 2 
In breast cancer gene expression data, a combination approach using LDA, 
DSGA and TDA was successfully used to differentiate breast cancer subtypes 
and identify relevant genes/pathways associated with specific subtypes. Some of 
the observations include 
 
• LDA alone was not successful in classifying breast cancer subtypes based 
on gene expression data. Significant difference was observed in LDA topic 
separation after feature reduction using DSGA. LDA+DSGA performed the 
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best compared to others in classifying multiple subtypes. When comparing 
one-vs.-rest classes, LDA+DSGA still performed the best except for ER 
and Luminal A, where, SVM+DSGA outperformed LDA although, all three 
tested techniques resulted in very high accuracy. Further, topological 
differences in gene expression from breast cancer subtype data before 
and after DSGA-LDA resulted in separate clusters. 
• LDA-DSGA-TDA classification model was successfully applied to identify 
known genes/pathways that contributed the most to differences between 
breast cancer subtypes. 
 
 
Specific aim 3 
Highly accurate classification approach was constructed using LDA-DSGA-TDA 
for classifying skin cutaneous melanoma from benign nevi based on copy 
number data and the top distinctive chromosomal position/genes were identified. 
Some of the observations are 
 
• Compared to rank-based, threshold-based approach was effective in 
converting copy number data to text in terms of accuracy and 
computational time. 
 
• Differences in copy number profiles of melanoma and nevi samples were 
successfully modelled using LDA-DSGA-TDA approach. DSGA+RF 
performed the best followed by DSGA+LDA and LDA alone performed the 
worst, albeit, all tested techniques showed very high performance. 
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• Classification model based on the above approach using copy number 
data from melanoma and nevi samples was successfully applied to 
identify the known main drivers of the separation between these two 
groups. 
We believe that LDA is a promising method with numerous applications to 
biomedical research. The above specific aims showed that LDA can accomplish 
the task of clustering and classification of cancer genomic data. Furthermore, 
each topic is interpreted as a probability distribution over words. That is, 
compared with black-box algorithms, LDA can produce a more understandable 
result and thus may help a biologist to interpret the finding. Meanwhile, unlike 
traditional clustering, LDA allows data to come from a mixture of clusters rather 
than from a single cluster. These characteristics may be useful in bioinformatics. 
However, for hard-to-classify problems when LDA alone is not effective, we 
identified that LDA+DSGA, a method that unravels the disease characteristics of 
high dimensional genomic/proteomic data is effective. That is DSGA when 
precedes standard class prediction techniques like SVM, RF or LDA enhances 
their performance and ability to classify. 
 
Overall our proposed pipeline provides a novel direction for applying the 
LDA algorithm to identify and group differentially expressed genes between 
healthy and cancer tissues of various types. A novel technique for transformation 
of gene expression levels to words is presented and shown to be effective. 
Comparative evaluation of this approach with state-of-the-art pattern 
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classification methods confirms the effectiveness of the proposed methodology. 
Differential gene expression patterns associated with lung cancer, breast cancer, 
breast cancer subtypes and melanoma were identified as relevant using pathway 
analysis and the NIH’s genetic association database. 
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VI. FUTURE DIRECTIONS 
 
           It has been demonstrated that the crucial factor in the application of LDA 
to genomic data is the parameter selection like the number of topics. Choosing 
the ideal number of topics is important for the overall distribution of words in LDA 
that further affects the classification performance. One of the future directions 
includes automating the selection of topics.              
           Other important issues that need to be addressed include testing and 
validating the genes and pathways identified using our classification approach. 
Our data showed that LDA-based functional analysis of cancer gene expression 
data identified many relevant genes and pathways. Although these observations 
suggest that LDA-based classification identified relevant genes differentiating the 
different types of cancer, associating a validation metric can enhance the 
significance of the study. Therefore, it will be worthy to further validate the 
identified genes. This will be achieved by Precision @ k, a useful metric in text 
mining that gives the fraction of relevant results out of the first k returned (for 
example, P@10 or "Precision at 10" corresponds to the number of relevant 
results on the first 10 returned). The same can be applied here by collecting N 
known cancer related genes and at a cutoff k, calculating the precision of the N 
known genes.  This gives us a validation of the gene subsets from our 
classification.
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         Lastly, other set of experiments that are worthy to carry out include   
investigating other types of classifiers and build an ensemble classifier. Lots of best 
classification approaches currently put together lots of different techniques and vote 
(ensemble methods) (Sung et al, 2003, Hijazi et al, 2012, Nagi et al, 2013). These 
experiments will therefore provide another voter, which is valuable because it gives 
additional information to get better overall performance. 
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